Patrick Maloney Purchases CME Group Shares

Patrick Maloney acquired 645 shares of CME Group Inc. on June 25, 2026.

Key Points

  • Patrick Maloney bought 645 shares of CME Group Inc. at $225 each, totaling $145,125 on June 25, 2026.
  • CME Group Inc. has a market cap of $79.85 billion and a P/E ratio of 18.87, with shares trading near $221.0 on Tuesday.
  • Rothschild & Co upgraded CME to 'buy' with a $323 target; Morgan Stanley maintained 'buy' with a $353 target.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Patrick Maloney, an insider at CME Group Inc., purchased 645 shares of the company on June 25, 2026. The shares were bought at an average price of $225 each, amounting to a total transaction value of $145,125. This transaction was not conducted under a pre-planned trading program.

Insider Buying and Selling at CME Group Inc.

On June 25, 2026, several insiders at CME Group Inc. purchased shares. Phyllis Lockett, Howard Siegel, William Shepard, Rahael Seifu, Bryan Durkin, and Patrick Maloney each bought 645 shares, while Howard Siegel and William Shepard each acquired 1,067 shares. All purchases were made at $225 per share.

Other Institutional Activity in CME Group

Several institutional investors have adjusted their positions in CME Group. BlackRock, Inc. increased its holdings by 370,381 shares, bringing its total to 31,448,257 shares worth approximately $9.29 billion, a 1.2% increase. Vanguard Capital Management LLC opened a new position with 23,367,282 shares valued at about $6.90 billion. State Street Corp reduced its holdings slightly by 89,238 shares, now holding 16,055,287 shares worth $4.74 billion, a 0.6% decrease. Meanwhile, JPMorgan Chase & Co and Morgan Stanley increased their stakes by 1,108,304 and 1,043,692 shares, respectively, with JPMorgan's shares valued at $3.63 billion, marking a 10% increase, and Morgan Stanley's at $2.78 billion, a 12.5% increase.

CME Group Inc. Stock Down 23.5%

Shares of NasdaqGS:CME traded near $221.0 on Tuesday. CME Group Inc. boasts a market cap of $79.85 billion and a P/E ratio of 18.87, indicating its profitability. The stock has a 52-week low of $220.73 and a high of $329.16, with a 50-day moving average of $273.98 and a 200-day moving average of $280.89. The company's beta is 0.244, suggesting lower volatility compared to the market.

Year to date

$CME stock price

Daily closing prices, year to date. Not investment advice.

Recent Earnings

CME Group Inc. reported revenue of approximately $6.74 billion, with a revenue growth of 14.4%. Its net margin stands at 63.32%, and return on equity at 15.92%. The company has an EPS of $11.71. Investors can look forward to the next earnings release on July 22, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 28/100

Reported Apr 22, 2026

  1. Forward outlook

    2 target cuts vs 0 raises.

  2. EPS & revenue

    EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.

  3. Profit surprise

    EBITDA missed by 6 percent. Operating income missed by 5 percent.

  4. Pre-earnings setup

    Expectations were about average.

  5. Analyst signal

    2 target cuts.

  6. Earnings quality

    Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.

Earnings Call Summary

CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.

Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Dividend

CME Group Inc. offers an annual dividend rate of $5.20 per share, yielding 2.35%. The dividend payout ratio is a high 95.56%, reflecting the company's commitment to returning capital to shareholders.

Analysts Set New Price Targets

On June 11, 2026, Rothschild & Co upgraded CME Group Inc. to a 'buy' rating, setting a price target of $323. Morgan Stanley has maintained its 'buy' rating with a target of $353, while Barclays has kept a 'hold' rating with a target of $316. The consensus among 15 analysts is a 'buy', with a mean price target of $302.60.

About CME Group

CME Group Inc., based in Chicago, Illinois, operates global markets for trading futures and options. It offers products based on interest rates, equity indexes, and foreign exchange, as well as commodities like agriculture, energy, and metals. The company also provides clearing services and market data to a range of clients, including professional traders and financial institutions. Led by CEO Terrence A. Duffy, CME Group employs about 3,875 people.

Bottom Line

Patrick Maloney's recent purchase of CME Group shares highlights ongoing insider interest in the company. While the stock trades near its 52-week low, analysts maintain positive outlooks with several 'buy' ratings and targets above current levels. As always, remember that insider transactions and analyst ratings provide insight into market sentiment but are not recommendations.

Get CME Group Inc. alerts

New 13F filings, insider trades, and analyst moves on $CME, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.